Profile data is unavailable for this security.
About the company
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
- Revenue in USD (TTM)142.09m
- Net income in USD-35.73m
- Incorporated2016
- Employees498.00
- LocationRxsight Inc100 COLUMBIA STREET, SUITE 120ALISO VIEJO 92656United StatesUSA
- Phone+1 (949) 521-7822
- Fax+1 (302) 655-5049
- Websitehttps://www.rxsight.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 908 Devices Inc | 57.64m | -57.10m | 232.00m | 246.00 | -- | 1.70 | -- | 4.03 | -1.61 | -0.1116 | 1.62 | 3.77 | 0.3123 | 1.76 | 4.17 | 234,296.80 | -30.94 | -18.01 | -37.82 | -19.67 | 49.35 | 52.89 | -99.07 | -78.45 | 3.12 | -- | 0.00 | -- | 18.72 | 27.11 | -98.37 | -- | 8.96 | -- |
| Simulations Plus Inc | 78.68m | -64.25m | 243.98m | 212.00 | -- | 1.92 | -- | 3.10 | -3.20 | -3.20 | 3.90 | 6.31 | 0.4701 | -- | 4.28 | 371,113.20 | -38.39 | -2.50 | -40.84 | -2.65 | 59.60 | 69.96 | -81.66 | -7.29 | -- | -- | 0.00 | -- | 13.09 | 13.74 | -750.17 | -- | 7.57 | -24.21 |
| Applied Energetics Inc | 1.15m | -13.02m | 261.43m | 21.00 | -- | -- | -- | 226.73 | -0.0599 | -0.0599 | 0.0053 | -0.0033 | 0.3065 | -- | 7.70 | 54,908.57 | -345.27 | -139.08 | -454.84 | -208.36 | 58.58 | 60.61 | -1,126.59 | -473.16 | -- | -- | -- | -- | -7.78 | -- | -24.71 | -- | 51.42 | -- |
| Quanterix Corp | 130.20m | -95.66m | 275.13m | 471.00 | -- | 0.8742 | -- | 2.11 | -2.33 | -2.33 | 3.21 | 6.74 | 0.3045 | 1.44 | 4.06 | 276,439.50 | -22.37 | -13.18 | -25.81 | -14.53 | 51.53 | 56.14 | -73.47 | -45.09 | 2.31 | -- | 0.0029 | -- | 12.30 | 19.36 | -35.89 | -- | -20.86 | -- |
| Shoulder Innovations Inc | 41.63m | -34.45m | 282.66m | 61.00 | -- | 1.91 | -- | 6.79 | -1.91 | -1.91 | 2.24 | 7.18 | -- | -- | -- | -- | -- | -- | -- | -- | 76.67 | -- | -82.75 | -- | 9.80 | -- | 0.0913 | -- | 64.07 | -- | -50.85 | -- | -- | -- |
| Trubridge Inc | 349.88m | 5.42m | 282.92m | 3.20k | 50.82 | 1.57 | 8.82 | 0.8086 | 0.3709 | 0.3709 | 24.23 | 12.02 | 0.8737 | 257.08 | 6.17 | 109,338.40 | 1.39 | -0.9107 | 1.60 | -1.03 | 53.16 | 50.13 | 1.59 | -1.14 | 1.90 | 2.40 | 0.4768 | -- | 0.946 | 4.52 | 56.05 | -- | 61.10 | -- |
| Sight Sciences Inc | 76.05m | -46.11m | 284.98m | 216.00 | -- | 4.40 | -- | 3.75 | -0.8955 | -0.8955 | 1.47 | 1.23 | 0.5854 | 1.42 | 6.71 | 352,092.60 | -35.49 | -35.50 | -39.37 | -38.53 | 86.83 | 82.63 | -60.63 | -94.20 | 8.93 | -76.38 | 0.384 | -- | -1.47 | 27.89 | 7.27 | -- | -10.54 | -- |
| Carlsmed Inc | -100.00bn | -100.00bn | 286.14m | 100.00 | -- | 2.68 | -- | -- | -- | -- | -- | 4.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 11.91 | -- | 0.1265 | -- | 97.16 | -- | -31.49 | -- | -- | -- |
| Owlet Inc | 99.64m | -42.45m | 290.42m | 80.00 | -- | -- | -- | 2.91 | -2.75 | -2.75 | 6.08 | -2.34 | 1.52 | 3.80 | 4.36 | 1,245,500.00 | -60.37 | -64.44 | -244.32 | -331.11 | 52.06 | 44.29 | -39.68 | -58.72 | 0.9074 | -2.48 | -- | -- | 44.52 | 9.40 | 54.08 | -- | -17.23 | -- |
| Evolent Health Inc | 2.05bn | -180.89m | 294.63m | 4.50k | -- | 0.3498 | -- | 0.1434 | -1.57 | -1.57 | 17.85 | 7.55 | 0.829 | -- | 5.17 | 456,456.00 | -5.17 | -5.93 | -6.41 | -8.00 | 18.42 | 21.07 | -6.24 | -7.16 | -- | 0.189 | 0.5572 | -- | 30.09 | 30.04 | 34.31 | -- | -6.87 | -- |
| Senseonics Holdings Inc | 29.30m | -63.77m | 309.71m | 117.00 | -- | 3.96 | -- | 10.57 | -1.65 | -1.65 | 0.7565 | 1.92 | 0.248 | 3.62 | 5.22 | 250,410.30 | -53.98 | -71.11 | -70.98 | -94.75 | 41.11 | -14.81 | -217.65 | -594.09 | 5.93 | -29.18 | 0.3109 | -- | 0.3662 | 1.08 | -30.18 | -- | 16.46 | -- |
| Rxsight Inc | 142.09m | -35.73m | 320.71m | 498.00 | -- | 1.16 | -- | 2.26 | -0.8782 | -0.8782 | 3.50 | 6.72 | 0.4591 | 1.40 | 5.74 | 285,313.30 | -11.54 | -19.50 | -12.45 | -21.50 | 74.98 | 57.17 | -25.15 | -52.00 | 11.44 | -- | 0.0004 | -- | 57.09 | 128.61 | 43.52 | -- | 5.89 | -- |
| Delcath Systems Inc | 79.60m | 1.20m | 322.06m | 96.00 | 1,048.28 | 2.80 | 231.03 | 4.05 | 0.0087 | 0.0087 | 2.10 | 3.25 | 1.02 | 1.26 | 7.70 | 829,197.90 | 1.54 | -94.54 | 1.90 | -143.97 | 86.29 | 81.31 | 1.50 | -339.85 | 13.71 | -- | 0.00 | -- | 1,701.70 | 88.10 | 44.66 | -- | 87.69 | -- |
| Clearpoint Neuro Inc | 34.33m | -23.14m | 387.92m | 115.00 | -- | 23.35 | -- | 11.30 | -0.8264 | -0.8264 | 1.23 | 0.5584 | 0.6829 | 1.95 | 7.52 | 298,539.10 | -46.03 | -35.94 | -54.48 | -41.48 | 61.31 | 63.49 | -67.40 | -74.87 | 5.56 | -92.37 | 0.6479 | -- | 31.04 | 22.85 | 14.37 | -- | 11.41 | -- |
Data as of Feb 13 2026. Currency figures normalised to Rxsight Inc's reporting currency: US Dollar USD
38.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 2.25m | 5.47% |
| Millennium Management LLCas of 30 Sep 2025 | 2.19m | 5.33% |
| Artisan Partners LPas of 31 Dec 2025 | 2.16m | 5.25% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.97m | 4.79% |
| D. E. Shaw & Co. LPas of 30 Sep 2025 | 1.83m | 4.46% |
| No Street GP LPas of 30 Sep 2025 | 1.63m | 3.95% |
| Citadel Advisors LLCas of 30 Sep 2025 | 1.11m | 2.71% |
| DWS Investments (UK) Ltd.as of 30 Sep 2025 | 952.54k | 2.32% |
| BNP Paribas Financial Marketsas of 30 Sep 2025 | 903.85k | 2.20% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 824.14k | 2.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
